首页> 美国卫生研究院文献>other >ViDa1: The Development and Validation of a New Questionnaire for Measuring Health-Related Quality of Life in Patients with Type 1 Diabetes
【2h】

ViDa1: The Development and Validation of a New Questionnaire for Measuring Health-Related Quality of Life in Patients with Type 1 Diabetes

机译:ViDa1:制定和验证一种用于测量1型糖尿病患者健康相关生活质量的新问卷

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study describes the development of a new questionnaire to measure health-related quality of life (HRQoL) in patients with type 1 diabetes (the ViDa1 questionnaire) and provides information on its psychometric properties. For its development, open interviews with patients took place and topics relevant to patients' HRQoL were identified and items were generated. Qualitative analysis of items, expert review, and refinement of the questionnaire followed. A pilot study (N = 150) was conducted to explore the underlying structure of the 40-item ViDa1 questionnaire. A Principal Component Analysis (PCA) was performed and six of the items that did not load on any of the factors were eliminated. The results supported a four-dimensional structure for ViDa1, the dimensions being Interference of diabetes in everyday life, Self-care, Well-being, and Worry about the disease. Subsequently, the PCA was repeated in a larger sample (N = 578) with the reduced 34-item version of the questionnaire, and a Confirmatory Factor Analysis (CFA) was performed (N = 428). Overall fit indices obtained presented adequate values which supported the four-factor model initially proposed [(χ(df=554)2= 2601.93) (p < 0.001); Root Mean Square Error of Approximation = 0.060 (CI = 0.056 −0.064)]. As regards reliability, the four dimensions of the ViDa1 demonstrated good internal consistency, with Cronbach's alphas ranging between 0.71 and 0.86. Evidence of convergent-discriminant validity in the form of high correlations with another specific HRQoL questionnaire for diabetes and low correlations with other constructs such as self-efficacy, anxiety, and depression were presented. The ViDa1 also discriminated between different aspects of clinical interest such as type of insulin treatment, presence of chronic complications, and glycemic control, temporal stability, and sensitivity to change after an intervention. In conclusion, the ViDa1 questionnaire presents adequate psychometric properties and may represent a good alternative for the evaluation of HRQoL in type 1 diabetes.
机译:这项研究描述了一种用于测量1型糖尿病患者健康相关生活质量(HRQoL)的新问卷的开发(ViDa1问卷),并提供了有关其心理计量特性的信息。为了发展它,对患者进行了公开访谈,并确定了与患者HRQoL相关的主题并生成了项目。随后对项目进行定性分析,专家审查和完善问卷。进行了一项初步研究(N = 150)以探索40项ViDa1问卷的基本结构。进行了主成分分析(PCA),并删除了六个未加载到任何因素上的项目。结果支持了ViDa1的四维结构,即糖尿病在日常生活中的干扰,自我保健,幸福感和对疾病的担忧。随后,在减少了34个项目的问卷中,在较大的样本(N = 578)中重复PCA,并进行了确认因素分析(CFA)(N = 428)。获得的总体拟合指数呈现出足够的值,该值支持最初提出的四因子模型[[ χ d f = 554 < mrow> 2 = 2601.93)(p <0.001);近似均方根误差= 0.060(CI = 0.056 -0.064)]。在可靠性方面,ViDa1的四个维度均显示出良好的内部一致性,克朗巴赫的alpha介于0.71至0.86之间。呈递收敛判别效度的证据是,与另一项针对糖尿病的特定HRQoL调查表高度相关,而与其他结构(如自我效能,焦虑和抑郁)的相关性较低。 ViDa1还区分了临床关注的不同方面,例如胰岛素治疗的类型,是否存在慢性并发症以及血糖控制,时间稳定性以及干预后变化的敏感性。总之,ViDa1问卷具有足够的心理计量学特性,可能是评估1型糖尿病HRQoL的良好选择。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号